Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Viking Therapeutics Inc has a consensus price target of $77.58 based on the ratings of 19 analysts. The high is $138 issued by Oppenheimer on September 25, 2024. The low is $12 issued by SVB Leerink on April 28, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Scotiabank, and Citigroup on March 11, 2025, February 13, 2025, and February 7, 2025, respectively. With an average price target of $80.67 between HC Wainwright & Co., Scotiabank, and Citigroup, there's an implied 179.12% upside for Viking Therapeutics Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/11/2025 | Buy Now | 252.94% | HC Wainwright & Co. | Joseph Pantginis46% | $102 → $102 | Reiterates | Buy → Buy | Get Alert |
02/13/2025 | Buy Now | 252.94% | Scotiabank | George Farmer50% | → $102 | Initiates | → Sector Outperform | Get Alert |
02/07/2025 | Buy Now | 31.49% | Citigroup | David Lebowitz51% | → $38 | Initiates | → Neutral | Get Alert |
02/07/2025 | Buy Now | 142.21% | Maxim Group | Naz Rahman28% | $120 → $70 | Maintains | Buy | Get Alert |
02/07/2025 | Buy Now | 232.18% | B. Riley Securities | Mayank Mamtani72% | $109 → $96 | Reiterates | Buy → Buy | Get Alert |
02/06/2025 | Buy Now | 332.53% | Raymond James | Steven Seedhouse59% | $122 → $125 | Maintains | Strong Buy | Get Alert |
02/06/2025 | Buy Now | 145.67% | Piper Sandler | Biren Amin40% | $74 → $71 | Maintains | Overweight | Get Alert |
02/06/2025 | Buy Now | 252.94% | HC Wainwright & Co. | Joseph Pantginis46% | $102 → $102 | Reiterates | Buy → Buy | Get Alert |
01/17/2025 | Buy Now | 252.94% | HC Wainwright & Co. | Joseph Pantginis46% | $102 → $102 | Reiterates | Buy → Buy | Get Alert |
01/10/2025 | Buy Now | 252.94% | HC Wainwright & Co. | Joseph Pantginis46% | $102 → $102 | Reiterates | Buy → Buy | Get Alert |
01/08/2025 | Buy Now | 252.94% | HC Wainwright & Co. | Joseph Pantginis46% | $102 → $102 | Maintains | Buy | Get Alert |
12/20/2024 | Buy Now | 252.94% | HC Wainwright & Co. | Joseph Pantginis46% | $102 → $102 | Reiterates | Buy → Buy | Get Alert |
12/18/2024 | Buy Now | 252.94% | HC Wainwright & Co. | Joseph Pantginis46% | $102 → $102 | Reiterates | Buy → Buy | Get Alert |
12/02/2024 | Buy Now | 156.06% | Piper Sandler | Biren Amin40% | → $74 | Initiates | → Overweight | Get Alert |
11/27/2024 | Buy Now | 252.94% | HC Wainwright & Co. | Joseph Pantginis46% | $102 → $102 | Reiterates | Buy → Buy | Get Alert |
11/26/2024 | Buy Now | 252.94% | HC Wainwright & Co. | Joseph Pantginis46% | $102 → $102 | Reiterates | Buy → Buy | Get Alert |
11/22/2024 | Buy Now | 277.16% | B. Riley Securities | Mayank Mamtani72% | → $109 | Initiates | → Buy | Get Alert |
11/05/2024 | Buy Now | 252.94% | HC Wainwright & Co. | Joseph Pantginis46% | $90 → $102 | Maintains | Buy | Get Alert |
10/24/2024 | Buy Now | 211.42% | HC Wainwright & Co. | Joseph Pantginis46% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
10/09/2024 | Buy Now | 211.42% | HC Wainwright & Co. | Joseph Pantginis46% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
09/25/2024 | Buy Now | 377.51% | Oppenheimer | Jay Olson62% | $138 → $138 | Reiterates | Outperform → Outperform | Get Alert |
09/12/2024 | Buy Now | 263.32% | Morgan Stanley | Michael Ulz58% | $105 → $105 | Reiterates | Overweight → Overweight | Get Alert |
09/11/2024 | Buy Now | 176.82% | JP Morgan | Hardik Parikh10% | → $80 | Initiates | → Overweight | Get Alert |
07/25/2024 | Buy Now | 308.3% | Raymond James | Steven Seedhouse59% | $116 → $118 | Maintains | Strong Buy | Get Alert |
07/25/2024 | Buy Now | 211.42% | HC Wainwright & Co. | Joseph Pantginis46% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
06/27/2024 | Buy Now | 263.32% | Morgan Stanley | Michael Ulz58% | → $105 | Initiates | → Overweight | Get Alert |
06/24/2024 | Buy Now | 211.42% | HC Wainwright & Co. | Joseph Pantginis46% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
06/17/2024 | Buy Now | 315.22% | Truist Securities | Joon Lee78% | $120 → $120 | Maintains | Buy | Get Alert |
06/04/2024 | Buy Now | — | Raymond James | Steven Seedhouse59% | — | Reiterates | → Strong Buy | Get Alert |
06/04/2024 | Buy Now | 315.22% | Maxim Group | Naz Rahman28% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
06/04/2024 | Buy Now | 211.42% | HC Wainwright & Co. | Joseph Pantginis46% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
05/16/2024 | Buy Now | 315.22% | Truist Securities | Joon Lee78% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
05/16/2024 | Buy Now | 301.38% | Raymond James | Steven Seedhouse59% | $115 → $116 | Upgrade | Outperform → Strong Buy | Get Alert |
04/25/2024 | Buy Now | 211.42% | HC Wainwright & Co. | Joseph Pantginis46% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
03/27/2024 | Buy Now | 377.51% | Oppenheimer | Jay Olson62% | $116 → $138 | Maintains | Outperform | Get Alert |
03/26/2024 | Buy Now | 211.42% | HC Wainwright & Co. | Joseph Pantginis46% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
03/26/2024 | Buy Now | 377.51% | Oppenheimer | Jay Olson62% | $116 → $138 | Maintains | Outperform | Get Alert |
03/26/2024 | Buy Now | 332.53% | BTIG | Justin Zelin41% | $100 → $125 | Maintains | Buy | Get Alert |
03/15/2024 | Buy Now | 211.42% | HC Wainwright & Co. | Joseph Pantginis46% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
03/15/2024 | Buy Now | 315.22% | Maxim Group | Naz Rahman28% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
03/15/2024 | Buy Now | 176.82% | Stifel | Annabel Samimy68% | → $80 | Reiterates | Buy → Buy | Get Alert |
03/15/2024 | Buy Now | 246.02% | BTIG | Justin Zelin41% | $86 → $100 | Maintains | Buy | Get Alert |
03/08/2024 | Buy Now | 211.42% | HC Wainwright & Co. | Joseph Pantginis46% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
03/07/2024 | Buy Now | 280.62% | Jefferies | Roger Song33% | → $110 | Initiates | → Buy | Get Alert |
02/29/2024 | Buy Now | 315.22% | Truist Securities | Joon Lee78% | $32 → $120 | Maintains | Buy | Get Alert |
02/28/2024 | Buy Now | 301.38% | Oppenheimer | Jay Olson62% | $46 → $116 | Maintains | Outperform | Get Alert |
02/27/2024 | Buy Now | 297.92% | Raymond James | Steven Seedhouse59% | $37 → $115 | Maintains | Outperform | Get Alert |
02/27/2024 | Buy Now | 211.42% | HC Wainwright & Co. | Joseph Pantginis46% | $33 → $90 | Maintains | Buy | Get Alert |
02/14/2024 | Buy Now | 21.11% | Stifel | Annabel Samimy68% | $30 → $35 | Maintains | Buy | Get Alert |
02/08/2024 | Buy Now | 73.01% | Maxim Group | Naz Rahman28% | $35 → $50 | Maintains | Buy | Get Alert |
12/04/2023 | Buy Now | 10.73% | Truist Securities | Joon Lee78% | → $32 | Reiterates | Buy → Buy | Get Alert |
10/02/2023 | Buy Now | 10.73% | Truist Securities | Joon Lee78% | → $32 | Reiterates | Buy → Buy | Get Alert |
08/08/2023 | Buy Now | 3.81% | Stifel | Annabel Samimy68% | → $30 | Reiterates | → Buy | Get Alert |
07/27/2023 | Buy Now | 14.19% | HC Wainwright & Co. | Joseph Pantginis46% | → $33 | Reiterates | Buy → Buy | Get Alert |
06/27/2023 | Buy Now | 10.73% | Truist Securities | Joon Lee78% | → $32 | Reiterates | Buy → Buy | Get Alert |
05/31/2023 | Buy Now | 10.73% | Roth MKM | Dylan Dupuis61% | → $32 | Assumes | → Buy | Get Alert |
05/17/2023 | Buy Now | 28.03% | Raymond James | Steven Seedhouse59% | $35 → $37 | Maintains | Outperform | Get Alert |
05/16/2023 | Buy Now | 38.41% | Oppenheimer | Jay Olson62% | $35 → $40 | Maintains | Outperform | Get Alert |
05/16/2023 | Buy Now | 3.81% | Stifel | Annabel Samimy68% | $25 → $30 | Maintains | Buy | Get Alert |
05/16/2023 | Buy Now | 24.57% | BTIG | Justin Zelin41% | $31 → $36 | Maintains | Buy | Get Alert |
05/08/2023 | Buy Now | 14.19% | HC Wainwright & Co. | Joseph Pantginis46% | → $33 | Reiterates | → Buy | Get Alert |
05/03/2023 | Buy Now | -16.96% | Roth MKM | Scott Henry47% | $19 → $24 | Maintains | Buy | Get Alert |
04/27/2023 | Buy Now | 21.11% | Oppenheimer | Jay Olson62% | → $35 | Reiterates | → Outperform | Get Alert |
04/27/2023 | Buy Now | 14.19% | HC Wainwright & Co. | Joseph Pantginis46% | $21 → $33 | Maintains | Buy | Get Alert |
04/25/2023 | Buy Now | 21.11% | Oppenheimer | Jay Olson62% | $30 → $35 | Maintains | Outperform | Get Alert |
03/29/2023 | Buy Now | -34.26% | Roth MKM | Matt Koranda54% | $15 → $19 | Maintains | Buy | Get Alert |
03/29/2023 | Buy Now | -13.49% | Maxim Group | Anthony Vendetti57% | $15 → $25 | Maintains | Buy | Get Alert |
03/29/2023 | Buy Now | 10.73% | Truist Securities | Joon Lee78% | $28 → $32 | Maintains | Buy | Get Alert |
03/29/2023 | Buy Now | 21.11% | Raymond James | Steven Seedhouse59% | $12 → $35 | Maintains | Outperform | Get Alert |
03/29/2023 | Buy Now | 7.27% | BTIG | Justin Zelin41% | $20 → $31 | Maintains | Buy | Get Alert |
03/28/2023 | Buy Now | 3.81% | Oppenheimer | Jay Olson62% | $20 → $30 | Maintains | Outperform | Get Alert |
03/28/2023 | Buy Now | -13.49% | Stifel | Annabel Samimy68% | $22 → $25 | Maintains | Buy | Get Alert |
03/17/2023 | Buy Now | -23.88% | Stifel | Annabel Samimy68% | → $22 | Initiates | → Buy | Get Alert |
02/09/2023 | Buy Now | -58.48% | Raymond James | Steven Seedhouse59% | $11 → $12 | Maintains | Outperform | Get Alert |
02/09/2023 | Buy Now | -27.34% | HC Wainwright & Co. | Joseph Pantginis46% | → $21 | Reiterates | → Buy | Get Alert |
12/20/2022 | Buy Now | -48.1% | Maxim Group | Naz Rahman28% | $10 → $15 | Maintains | Buy | Get Alert |
10/27/2022 | Buy Now | -61.94% | Raymond James | Steven Seedhouse59% | $10 → $11 | Maintains | Outperform | Get Alert |
04/28/2022 | Buy Now | -58.48% | SVB Leerink | Thomas Smith33% | $18 → $12 | Maintains | Outperform | Get Alert |
The latest price target for Viking Therapeutics (NASDAQ:VKTX) was reported by HC Wainwright & Co. on March 11, 2025. The analyst firm set a price target for $102.00 expecting VKTX to rise to within 12 months (a possible 252.94% upside). 38 analyst firms have reported ratings in the last year.
The latest analyst rating for Viking Therapeutics (NASDAQ:VKTX) was provided by HC Wainwright & Co., and Viking Therapeutics reiterated their buy rating.
The last upgrade for Viking Therapeutics Inc happened on May 16, 2024 when Raymond James raised their price target to $116. Raymond James previously had an outperform for Viking Therapeutics Inc.
There is no last downgrade for Viking Therapeutics.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Viking Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Viking Therapeutics was filed on March 11, 2025 so you should expect the next rating to be made available sometime around March 11, 2026.
While ratings are subjective and will change, the latest Viking Therapeutics (VKTX) rating was a reiterated with a price target of $102.00 to $102.00. The current price Viking Therapeutics (VKTX) is trading at is $28.90, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.